AstraZeneca PLC
AZNNYSE
Product information
What is AstraZeneca PLC (AZN)?
AstraZeneca PLC is a biopharmaceutical company based in Cambridge, England. Its shares trade on the London Stock Exchange and Nasdaq Stockholm; in the US, since February 2026 its ordinary shares, rather than depositary receipts, have traded directly on the NYSE under the ticker AZN.
The company's broadest therapy area is oncology; products in this field include Tagrisso for lung cancer, the immunotherapy Imfinzi and Enhertu, developed jointly with Daiichi Sankyo. Farxiga stands out in cardiovascular, renal and metabolic diseases, and Breztri and Fasenra in respiratory and immunology. Alexion, acquired in 2021, brought the company rare disease products such as Soliris and Ultomiris.
Those following AZN stock track clinical trial results, new approvals in the oncology portfolio, developments concerning its operations in China, drug pricing regulation in the US and manufacturing investments. The AstraZeneca page on Lzzo.com offers the price in US dollars, a chart with selectable periods and technical indicators.
Sources: astrazeneca.com
- Name
- AstraZeneca PLC
- Symbol
- AZN
- Market
- Stocks
What to look for in the technical analysis of AstraZeneca PLC
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…